发明名称 |
Combination of azelastine and fluticasone for nasal administration |
摘要 |
A pharmaceutical product or formulation, which comprises azelastine or a pharmaceutically acceptable salt, solvate or physiologically functional derivative thereof, and a steroid, or a pharmaceutical acceptable salt, solvate or physiologically functional derivative thereof, preferably the product or formulation being in a form suitable for nasal or ocular administration. |
申请公布号 |
US9259428(B2) |
申请公布日期 |
2016.02.16 |
申请号 |
US201514661720 |
申请日期 |
2015.03.18 |
申请人 |
Cipla Limited |
发明人 |
Lulla Amar;Malhotra Geena |
分类号 |
A61K31/56;A61K9/00;A61K31/55;A61K31/573;A61K31/58;A61K47/10;A61K47/18;A61K47/26;A61K47/38 |
主分类号 |
A61K31/56 |
代理机构 |
Conley Rose, P.C. |
代理人 |
Conley Rose, P.C. ;Carroll Rodney B. |
主权项 |
1. A method for the treatment of seasonal allergic rhinitis, comprising administration of a therapeutically effective amount of a nasal spray formulation comprising:
from 0.001% (weight/weight) to 1% (weight/weight) of azelastine hydrochloride; from 0.0357% (weight/weight) to 1.5% (weight/weight) of fluticasone propionate; one or more preservatives; one or more thickening agents; one or more surfactants; and one or more isotonization agents. |
地址 |
Mumbai IN |